The artificial expression of CD40L on the surface of any tumor-targeted CAR-T cell further provides an additional interesting opportunity to exploit CD40/CD40L signaling to stimulate endogenous anti-cancer T cell immunity. The gene discussed is CD40LG; the disease is cancer.